However, most studies consider TRPM2 a potential therapeutic target for antagonizing oxidative stress-related pathological conditions such as diabetes, inflammation, neurodegeneration, cardiovascular disease, and stroke [16, 41]. This evidence concerns the gene TRPM2 and cardiovascular disorder.